Uri Weinberg, Chief Innovation Officer at NovoCure Ltd (NVCR), sold 8,963 shares at $18.78 ($168K) on 2025-02-28, disclosed to the SEC on 2025-03-03.
Seasonal sale ($168k) by Chief Innovation Officer — this insider has traded NVCR in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.31 | 311 | $6K | 3.4% |
| 2 | $18.78 | 4,326 | $81K | 48.3% |
| 3 | $18.78 | 4,326 | $81K | 48.3% |
| Total | $18.76 avg | 8,963 | $168K | 100% |
| Filing → |
| NVCR | SELL | 2025-03-04 | $5K | — | Filing → |
| NVCR | SELL | 2023-01-09 | $946K | — | Filing → |
| NVCR | SELL | 2021-05-12 | $2.1M | — | Filing → |